Tarix investigational thrombocytopenia-reduction agent
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Tarix investigational thrombocytopenia-reduction agent, covering 2013-06-07 to 2013-06-07. Get the full timeline:
Most recent: Clinical Trial Update: Study of Drug to Reduce Thrombocytopenia in Patients Receiving Chemo for Ovarian, Fallopian Tube or Peritoneal Cancer [Phase 2]